The Biology of CXC Chemokines and Their Receptors

Current Topics in Membranes

Volumn 55, Issue , 2005, Pages 49-71

  Weathington, Nathaniel M ^a   Blalock, J Edwin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33644824897     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1063-5823(04)55002-0     Document Type: Review

References (75)

1. Ahuja S.K., Lee J.C., and Murphy P.M. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct. J. Biol. Chem. 271 (1996) 225-232
2. Ahuja S.K., and Murphy P.M. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J. Biol. Chem. 271 (1996) 20545-20550
3. Alblas J., Ulfman L., Hordijk P., and Koenderman L. Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. Mol. Biol. Cell 12 (2001) 2137-2145
4. Baggiolini M., Dewald B., and Moser B. Human chemokines: An update. Annu. Rev. Immunol. 15 (1997) 675-705
5. Barlic J., Andrews J.D., Kelvin A.A., Bosinger S.E., DeVries M.E., Xu L., Dobransky T., Feldman R.D., Ferguson S.S., and Kelvin D.J. Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI. Nat. Immunol. 1 (2000) 227-233
6. Barlic J., Khandaker M.H., Mahon E., Andrews J., DeVries M.E., Mitchell G.B., Rahimpour R., Tan C.M., Ferguson S.S., and Kelvin D.J. Beta-arrestins regulate interleukin-8-induced CXCR1 internalization. J. Biol. Chem. 274 (1999) 16287-16294
7. Bonecchi R., Facchetti F., Dusi S., Luini W., Lissandrini D., Simmelink M., Locati M., Bernasconi S., Allavena P., Brandt E., Rossi F., Mantovani A., and Sozzani S. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J. Immunol. 164 (2000) 3862-3869
8. Booth V., Clark-Lewis I., and Sykes B.D. NMR structure of CXCR3 binding chemokine CXCL11 (ITAC). Protein Sci. 13 (2004) 2022-2028
9. Burrows S.D., Doyle M.L., Murphy K.P., Franklin S.G., White J.R., Brooks I., McNulty D.E., Scott M.O., Knutson J.R., Porter D., Young P.R., and Hensley P. Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. Biochemistry 33 (1994) 12741-12745
10. Chabot D.J., Zhang P.F., Quinnan G.V., and Broder C.C. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates. J. Virol. 73 (1999) 6598-6609
11. Choi W.S., Kim Y.M., Combs C., Frohman M.A., and Beaven M.A. Phospholipases D1 and D2 regulate different phases of exocytosis in mast cells. J. Immunol. 168 (2002) 5682-5689
12. Clark-Lewis I., Dewald B., Loetscher M., Moser B., and Baggiolini M. Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J. Biol. Chem. 269 (1994) 16075-16081
13. Clore G.M., Appella E., Yamada M., Matsushima K., and Gronenborn A.M. Three-dimensional structure of interleukin-8 in solution. Biochemistry 29 (1990) 1689-1696
14. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Arenzana-Seisdedos F., Virelizier J.L., Baggiolini M., Sykes B.D., and Clark-Lewis I. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16 (1997) 6996-7007
15. Doranz B.J., Orsini M.J., Turner J.D., Hoffman T.L., Berson J.F., Hoxie J.A., Peiper S.C., Brass L.F., and Doms R.W. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions. J. Virol. 73 (1999) 2752-2761
16. Fernandez E.J., and Lolis E. Structure, function, and inhibition of chemokines. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 469-499
17. Forster R., Mattis A.E., Kremmer E., Wolf E., Brem G., and Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87 (1996) 1037-1047
18. Fulkerson P.C., Zimmermann N., Brandt E.B., Muntel E.E., Doepker M.P., Kavanaugh J.L., Mishra A., Witte D.P., Zhang H., Farber J.M., Yang M., Foster P.S., and Rothenberg M.E. Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9). Proc. Natl. Acad. Sci. USA 101 (2004) 1987-1992
19. Gerber N., Lowman H., Artis D.R., and Eigenbrot C. Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution. Proteins 38 (2000) 361-367
20. Hamm H.E. How activated receptors couple to G proteins. Proc. Natl. Acad. Sci. USA 98 (2001) 4819-4821
21. Hancock W.W., Lu B., Gao W., Csizmadia V., Faia K., King J.A., Smiley S.T., Ling M., Gerard N.P., and Gerard C. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192 (2000) 1515-1520
22. Hebert C.A., Chuntharapai A., Smith M., Colby T., Kim J., and Horuk R. Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain. J. Biol. Chem. 268 (1993) 18549-18553
23. Hebert C.A., Vitangcol R.V., and Baker J.B. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J. Biol. Chem. 266 (1991) 18989-18994
24. Hildebrandt G.C., Corrion L.A., Olkiewicz K.M., Lu B., Lowler K., Duffner U.A., Moore B.B., Kuziel W.A., Liu C., and Cooke K.R. Blockade of CXCR3 receptor: Ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. J. Immunol. 173 (2004) 2050-2059
25. Holmes W.E., Lee J., Kuang W.J., Rice G.C., and Wood W.I. Structure and functional expression of a human interleukin-8 receptor. Science 253 (1991) 1278-1280
26. Howard O.M., Oppenheim J.J., and Wang J.M. Chemokines as molecular targets for therapeutic intervention. J. Clin. Immunol. 19 (1999) 280-292
27. Huang Y.E., Iijima M., Parent C.A., Funamoto S., Firtel R.A., and Devreotes P. Receptor-mediated regulation of PI3Ks confines PI(3,4,5)P3 to the leading edge of chemotaxing cells. Mol. Biol. Cell 14 (2003) 1913-1922
28. Huising M.O., Stet R.J.M., Kruiswijk C.P., Savelkoul H.F.J., and Lidy Verburg-van Kemenade B.M. Molecular evolution of CXC chemokines: Extant CXC chemokines originate from the CNS. Trends in Immunology 24 (2003) 306-312
29. Jones S.A., Wolf M., Qin S., Mackay C.R., and Baggiolini M. Different functions for the interleukin-8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. PNAS 93 (1996) 6682-6686
30. Katancik J.A., Sharma A., and de Nardin E. Interleukin-8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2. Cytokine 12 (2000) 1480-1488
31. Kim C.H., Kunkel E.J., Boisvert J., Johnston B., Campbell J.J., Genovese M.C., Greenberg H.B., and Butcher E.C. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J. Clin. Invest. 107 (2001) 595-601
32. Kim C.H., Rott L., Kunkel E.J., Genovese M.C., Andrew D.P., Wu L., and Butcher E.C. Rules of chemokine receptor association with T cell polarization in vivo. J. Clin. Invest. 108 (2001) 1331-1339
33. Kurth I., Willimann K., Schaerli P., Hunziker T., Clark-Lewis I., and Moser B. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J. Exp. Med. 194 (2001) 855-861
34. Lee J., Horuk R., Rice G.C., Bennett G.L., Camerato T., and Wood W.I. Characterization of two high affinity human interleukin-8 receptors. J. Biol. Chem. 267 (1992) 16283-16287
35. Legler D.F., Loetscher M., Roos R.S., Clark-Lewis I., Baggiolini M., and Moser B. B cell-attracting chemokine-1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187 (1998) 655-660
36. Leong S.R., Kabakoff R.C., and Hebert C.A. Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction. J. Biol. Chem. 269 (1994) 19343-19348
37. Liston A., and McColl S. Subversion of the chemokine world by microbial pathogens. Bioessays 25 (2003) 478-488
38. Littman D.R. Chemokine receptors: Keys to AIDS pathogenesis?. Cell 93 (1998) 677-680
39. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., Baggiolini M., and Moser B. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184 (1996) 963-969
40. Loetscher P., Pellegrino A., Gong J.H., Mattioli I., Loetscher M., Bardi G., Baggiolini M., and Clark-Lewis I. The ligands of CXC chemokine receptor-3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J. Biol. Chem. 276 (2001) 2986-2991
41. Lowman H.B., Slagle P.H., De Forge L.E., Wirth C.M., Gillece-Castro B.L., Bourell J.H., and Fairbrother W.J. Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities. J. Biol. Chem. 271 (1996) 14344-14352
42. Mahler D.A., Huang S., Tabrizi M., and Bell G.M. Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: A pilot study. Chest 126 (2004) 926-934
43. Matloubian M., David A., Engel S., Ryan J.E., and Cyster J.G. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1 (2000) 298-304
44. Medoff B.D., Sauty A., Tager A.M., Maclean J.A., Smith R.N., Mathew A., Dufour J.H., and Luster A.D. IFN-gamma-inducible protein-10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J. Immunol. 168 (2002) 5278-5286
45. Moser B., and Willimann K. Chemokines: Role in inflammation and immune surveillance. Ann. Rheum. Dis. 63 Suppl 2 (2004) ii84-ii89
46. Murphy P.M. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2 (2001) 116-122
47. Murphy P.M. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54 (2002) 227-229
48. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., and Power C.A. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52 (2000) 145-176
49. Murphy P.M., and Tiffany H.L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253 (1991) 1280-1283
50. Nakayama T., Hieshima K., Izawa D., Tatsumi Y., Kanamaru A., and Yoshie O. Cutting edge: Profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J. Immunol. 170 (2003) 1136-1140
51. Nickel R., Beck L.A., Stellato C., and Schleimer R.P. Chemokines and allergic disease. J. Allergy Clin. Immunol. 104 (1999) 723-742
52. Nieto M., Frade J.M., Sancho D., Mellado M., Martinez A.C., and Sanchez-Madrid F. Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis. J. Exp. Med. 186 (1997) 153-158
53. Penfold M.E., Dairaghi D.J., Duke G.M., Saederup N., Mocarski E.S., Kemble G.W., and Schall T.J. Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl. Acad. Sci. USA 96 (1999) 9839-9844
54. Perrier P., Martinez F.O., Locati M., Bianchi G., Nebuloni M., Vago G., Bazzoni F., Sozzani S., Allavena P., and Mantovani A. Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: Induction of the B cell-activating chemokine, CXC chemokine ligand-13. J. Immunol. 172 (2004) 7031-7042
55. Peveri P., Walz A., Dewald B., and Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med. 167 (1988) 1547-1559
56. Proudfoot A.E. Chemokine receptors: Multifaceted therapeutic targets. Nat. Rev. Immunol. 2 (2002) 106-115
57. Rebecchi M.J., and Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 80 (2000) 1291-1335
58. Renzoni E., Lympany P., Sestini P., Pantelidis P., Wells A., Black C., Welsh K., Bunn C., Knight C., Foley P., and du Bois R.M. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis. Rheum. 43 (2000) 1633-1640
59. Revello M.G., Percivalle E., Arbustini E., Pardi R., Sozzani S., and Gerna G. In Vitro Generation of Human Cytomegalovirus pp65 Antigenemia, Viremia, and Leuko DNAemia. J. Clin. Invest. 101 (1998) 2686-2692
60. Ridley A.J., Allen W.E., Peppelenbosch M., and Jones G.E. Rho family proteins and cell migration. Biochem. Soc. Symp. 65 (1999) 111-123
61. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., and Horwitz A.R. Cell migration: Integrating signals from front to back. Science 302 (2003) 1704-1709
62. Roberts A.W., Kim C., Zhen L., Lowe J.B., Kapur R., Petryniak B., Spaetti A., Pollock J.D., Borneo J.B., Bradford G.B., Atkinson S.J., Dinauer M.C., and Williams D.A. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 10 (1999) 183-196
63. Rot A., and von Andrian U.H. Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22 (2004) 891-928
64. Samanta A.K., Oppenheim J.J., and Matsushima K. Identification and characterization of specific receptors for monocyte-derived neutrophil chemotactic factor (MDNCF) on human neutrophils. J. Exp. Med. 169 (1989) 1185-1189
65. Sanchez-Madrid F., and del Pozo M.A. Leukocyte polarization in cell migration and immune interactions. EMBO J. 18 (1999) 501-511
66. Sander E.E., ten Klooster J.P., van Delft S., van der Kammen R.A., and Collard J.G. Rac downregulates Rho activity: Reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell. Biol. 147 (1999) 1009-1022
67. Sotsios Y., and Ward S.G. Phosphoinositide 3-kinase: A key biochemical signal for cell migration in response to chemokines. Immunol. Rev. 177 (2000) 217-235
68. Thelen M., Peveri P., Kernen P., von Tscharner V., Walz A., and Baggiolini M. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J. 2 (1988) 2702-2706
69. Walz A., Peveri P., Aschauer H., and Baggiolini M. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem. Biophys. Res. Commun. 149 (1987) 755-761
70. Wang J.F., Park I.W., and Groopman J.E. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: Roles of phosphoinositide-3 kinase and protein kinase C. Blood 95 (2000) 2505-2513
71. Wang J.M., Su S., Gong W., and Oppenheim J.J. Chemokines, receptors, and their role in cardiovascular pathology. Int. J. Clin. Lab. Res. 28 (1998) 83-90
72. Whiting D., Hsieh G., Yun J.J., Banerji A., Yao W., Fishbein M.C., Belperio J., Strieter R.M., Bonavida B., and Ardehali A. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand-9 stimulates T lymphocyte proliferation and effector cytokine production. J. Immunol. 172 (2004) 7417-7424
73. Xu J., Wang F., Van Keymeulen A., Herzmark P., Straight A., Kelly K., Takuwa Y., Sugimoto N., Mitchison T., and Bourne H.R. Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils. Cell 114 (2003) 201-214
74. Yoshimura T., Matsushima K., Tanaka S., Robinson E.A., Appella E., Oppenheim J.J., and Leonard E.J. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 84 (1987) 9233-9237
75. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., and Littman D.R. Function of the chemokine receptor CXCR4 in hematopoiesis and in cerebellar development. Nature 393 (1998) 595-599